Rallybio Corporation - Common Stock (NQ:RLYB)

Halper Sadeh LLC is Investigating Whether RLYB, KALV, INM, TMHC are Obtaining Fair Deals for their Shareholders

June 02, 2026

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Taylor Morrison Home Corporation (NYSE - TMHC), Rallybio Corporation (Nasdaq – RLYB), InMed Pharmaceuticals, Inc. (Nasdaq – INM), KalVista Pharmaceuticals, Inc.

Performance

52-Week Range 7.0% below 52-week high

16.35

3.6752W Low 17.5752W High

1 Week 4.3% below 1-week high

16.201W Low 17.081W High

Rallybio Corporation - Common Stock (RLYB) traded between $3.67 and $17.57 over the past 52 weeks and last traded at $16.35, 7.0% below its 52-week high. Over the past week it ranged between $16.20 and $17.08.

Past 12 Months

-2.6%

-4.9%

-2.2%

+97.2%

+189.0%

+270.3%

1W -$0.44

1M -$0.84

3M -$0.36

6M +$8.06

YTD +$10.69

1Y +$11.93

RLYB was +270.3% over the past year, +97.2% over six months, +189.0% year to date, -2.6% in the last week.

12 Months vs Market

RLYB

+270.3%

DIA

+11.1%

SPY

+14.2%

QQQ

+17.5%

IWM

+9.3%

Over the past 12 months RLYB returned +270.3% versus DIA (Dow) +11.1%, SPY (S&P 500) +14.2%, QQQ (Nasdaq 100) +17.5% and IWM (Russell 2000) +9.3%.

Volume & Liquidity 0.53× 3-mo avg

Today 8,082 3-mo avg 15.4K

11.3K

9.0K

15.4K

129.2K

YTD

127.0K

106.7K

RLYB most recently traded 8,082 shares against a 3-month average daily volume of 15.4K.

More News

June 02, 2026

From Brodsky & Smith LLC

RLYB Stock Alert: Halper Sadeh LLC is Investigating Whether Rallybio Corporation is Obtaining a Fair Price for its Shareholders

RALLYBIO CORP (NASDAQ:RLYB) Passes Minervini Trend and High Growth Momentum Filters ↗

March 30, 2026

Via Chartmill

June 01, 2026

Rallybio Corporation and Avenzo Therapeutics Announce Merger Agreement to Advance Next-Generation Oncology Therapies and $215 Million Concurrent Private Placement

June 01, 2026

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

These stocks are moving in today's session ↗

May 04, 2026

Via Chartmill

May 04, 2026

Via Chartmill

Traders are paying attention to the gapping stocks in Monday's session. ↗

May 04, 2026

Via Chartmill

Discover the top movers in Monday's pre-market session. ↗

May 04, 2026

Via Chartmill

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Terns Therapeutics, Inc. (Nasdaq – TERN), Whitestone REIT (NYSE – WSR), Rallybio Corporation (Nasdaq – RLYB), Day One Biopharmaceuticals, Inc. (Nasdaq - DAWN)

April 09, 2026

From Brodsky & Smith LLC

Halper Sadeh LLC is Investigating Whether RLYB, TALK, UNF are Obtaining Fair Deals for their Shareholders

March 19, 2026

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Rallybio Corporation (Nasdaq – RLYB), SunOpta Inc. (Nasdaq – STKL), Talkspace, Inc. (Nasdaq - TALK), Kennedy-Wilson Holdings, Inc. (Nasdaq - KW)

March 18, 2026

From Brodsky & Smith LLC

Halper Sadeh LLC is Investigating Whether TALK, JTAI, RLYB are Obtaining Fair Deals for their Shareholders

March 17, 2026

Rallybio Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Rallybio Corporation - RLYB

March 04, 2026

From Kahn Swick & Foti, LLC

RLYB Stock Alert: Halper Sadeh LLC is Investigating Whether Rallybio Corporation is Obtaining a Fair Deal for its Shareholders

Monday's session: top gainers and losers ↗

March 02, 2026

Via Chartmill

March 02, 2026

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

March 02, 2026

Via Chartmill

Rallybio Corporation and Candid Therapeutics Announce Merger Agreement

March 02, 2026

From Candid Therapeutics, Inc.

Rallybio Announces Positive Data for RLYB116 Phase 1 Study Demonstrating Complete and Sustained Inhibition of Terminal Complement

February 17, 2026

Rallybio Announces Reverse Stock Split of Common Stock

February 03, 2026

RALLYBIO CORP (NASDAQ:RLYB) Reports Q3 2025 Earnings Beat Fueled by Asset Sale and Advances Clinical Pipeline ↗

November 06, 2025

Via Chartmill

Rallybio Reports Third Quarter 2025 Financial Results and Provides Business Updates

November 06, 2025